Authors: Xènia Puig-Bosch, M.Sc. et al Anesthesiology June 2022, Vol. 136, 954–969. Background Midazolam amplifies synaptic inhibition via different γ-aminobutyric acid type A (GABAA) receptor subtypes defined by the presence of α1-, α2-, α3-, or α5-subunits in the channel complex. Midazolam blocks long-term potentiation and produces postoperative amnesia. The aims of this study were to identify the GABAA receptor […]
Read MoreAuthors: Eliane Varga, M.D. et al Anesthesiology May 2022, Vol. 136, 827–828. The image depicts a 67-yr-old man who had significant periorbital skin injury after 5 h of prone spine surgery using a foam headrest with standard taping of eyes. The patient underwent facial laser skin resurfacing 2 months before the event. Facial pressure ulcers are a […]
Read MoreAuthor: Dibash Kumar Das, PhD ASA Monitor March 2021, Vol. 85, 34–35. Cardiothoracic surgeries are associated with significant pain. Optimal analgesia is a vital part of enhanced recovery after surgery strategies intended to improve patients’ perioperative experience and outcomes. Traditionally, analgesia in these types of surgeries has depended on large doses of I.V. opioids (Anesth Analg […]
Read MoreAuthors: Laurence Landow, M.D. et al Anesthesiology May 2022, Vol. 136, 868–870. To the Editor: The U.S. Food and Drug Administration (Silver Spring, Maryland) is requiring safety labeling changes to the prescribing information for hydroxyethyl starch products to warn about the risk of mortality, acute kidney injury (AKI), and coagulopathy in all patient populations. The changes […]
Read MoreASA Monitor June 2021, Vol. 85, 21. A recent observational cohort study compared the annualized rate of major adverse cardiac events (MACE) in patients with abnormal exercise electrocardiograms (+ECG) but normal stress echocardiograms (–Echo) to patients with normal exercise ECGs (–ECG) and normal stress echocardiograms (–Echo). According to this study, which of the following statements is […]
Read More